Chips · Stock report · Cohu (NASDAQ: COHU)
Cohu — ranks 71st of 86 chip stocks over one month, yet closed back above its 200-day average
The Closelooknet read
Cohu (NASDAQ: COHU) climbed back over its long-term line while sitting near the bottom of our chip section. It ranks 71st of the 86 stocks in our chip section by one-month move, down 24.7%. Our money-flow reading (a gauge of net buying pressure) is 105.1, still positive but slowing, down 7.7 over five sessions and 11 over 21. On Friday's close of $47.96, the stock finished above the average close of the last 200 sessions, $46.52, a cross up. We watch whether it holds above $46.52 in the coming sessions, or slips back under it.
Where Cohu stands among chip stocks
Cohu's one-month fall of 24.7% is deeper than most of its testing and metrology peers in our section. Advantest (6857.T) is up 0.9% over the month and Lasertec (6920.T) is down 2.7%. Teradyne (TER) fell 20.3%, FormFactor (FORM) 23.7%, Onto Innovation (ONTO) 29.0% and Aehr Test Systems (AEHR) 43.2%. Technoprobe (TPRO.MI) fell 16.4%. Cohu is 35.1% below its 30 June closing high of $73.91; Teradyne is 36.2% below its high from the same day and FormFactor 38.4%.
Our money-flow and quality readings
Our money-flow reading is 105.1, labelled warm, our label for the strength of net buying, and decelerating-up, meaning still positive but slowing. Cohu's composite score is 41 of 100. Its check of financial health, the Piotroski score, is scored 5 of 9. Among the parts, momentum (59), cash quality (57) and balance sheet (53) are the strongest. Capital allocation (38), growth (29), valuation (26) and quality (22) sit below the composite.
Price trend
Cohu rose 3.7% on the day to $47.96 after a 5.6% drop over five sessions. It is up 106.1% year to date and 120.5% over one year, and 124.3% above its 52-week closing low of $21.38 from 17 November 2025. The stock is 16.8% below its 50-day average of $57.64 and 3.1% above its 200-day average of $46.52. Its typical daily swing is about 5.2%.
Closelooknet is a research diary. Nothing here is investment advice or a recommendation to buy or sell.